Ge Healthcare Technologies Inc. ( (GEHC) ) has released its Q4 earnings. Here is a breakdown of the information Ge Healthcare Technologies Inc. presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
GE HealthCare Technologies Inc. is a leading global provider of healthcare solutions, specializing in medical technology, pharmaceutical diagnostics, and AI-enabled services, with a focus on improving patient care and healthcare efficiency.
In its latest earnings report, GE HealthCare announced a modest year-over-year revenue growth, with significant improvements in net income margin and earnings per share. The company highlighted strong demand in the U.S. market, particularly in its Advanced Visualization Solutions and Pharmaceutical Diagnostics sectors.
For the fourth quarter of 2024, the company reported a 2% increase in revenues, reaching $5.3 billion, driven by strong performance in specific segments. Net income surged to $720 million, up from $403 million the previous year, while diluted EPS rose from $0.88 to $1.57. Despite a decline in cash flow from operating activities, the company maintained a healthy free cash flow of $811 million.
Looking at the full-year results, GE HealthCare noted a 1% increase in total revenues, with a notable 27% rise in net income attributable to shareholders. The company also introduced its financial guidance for 2025, anticipating organic revenue growth of 2% to 3% and an adjusted EPS increase of up to 6% compared to 2024.
Moving forward, GE HealthCare plans to leverage its innovation and strategic partnerships to sustain growth. The company’s ongoing commitment to precision care and strategic investments are expected to drive future performance and enhance its market position in the healthcare sector.
